Mithlesh Kumar Temre

Employment

• National Institute on Aging Post Doctoral Fellow
  2023 - 2026
• BANARAS HINDU UNIVERSITY RESEARCH SCHOLAR (SRF)
  2018 - 2022

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• Telomere attrition alters extracellular vesicles conferring adverse impacts on neuronal viability and inflammatory response
  iScience 2025 DOI: 10.1016/j.isci.2025.112661
  +Save
• Glutor, a Glucose Transporter Inhibitor, Exerts Antineoplastic Action on Tumor Cells of Thymic Origin: Implication of Modulated Metabolism, Survival, Oxidative Stress, Mitochondrial Membrane Potential, pH Homeostasis, and Chemosensitivity
  Mithlesh Kumar Temre, Saveg Yadav, Yugal Goel

  +3 more

  • Shrish Kumar Pandey
  • Ajay Kumar
  • Sukh Mahendra Singh
  Frontiers in Oncology 2022 DOI: 10.3389/fonc.2022.925666
  +Save
• An appraisal of the current status of inhibition of glucose transporters as an emerging antineoplastic approach: Promising potential of new pan-GLUT inhibitors
  Frontiers in Pharmacology 2022 DOI: 10.3389/fphar.2022.1035510
  +Save
• Molecular characterization of glutor-GLUT interaction and prediction of glutor’s drug-likeness: implications for its utility as an antineoplastic agent
  Mithlesh Kumar Temre, Bharti Devi, Vinay Kumar Singh +6 more
  Journal of Biomolecular Structure and Dynamics 2022 DOI: 10.1080/07391102.2022.2161010
  +Save
• Methyl Jasmonate Cytotoxicity and Chemosensitization of T Cell Lymphoma In Vitro Is Facilitated by HK 2, HIF-1α, and Hsp70: Implication of Altered Regulation of Cell Survival, pH Homeostasis, Mitochondrial Functions
  Yugal Goel, Saveg Yadav, Shrish Kumar Pandey +4 more
  Frontiers in Pharmacology 2021 DOI: 10.3389/fphar.2021.628329
  +Save
• Tumor Decelerating and Chemo-Potentiating Action of Methyl Jasmonate on a T Cell Lymphoma In Vivo: Role of Altered Regulation of Metabolism, Cell Survival, Drug Resistance, and Intratumoral Blood Flow
  Yugal Goel, Saveg Yadav, Shrish Kumar Pandey

  +5 more

  • Mithlesh Kumar Temre
  • Babu Nandan Maurya
  • Ashish Kumar Verma
  • Ajay Kumar
  • Sukh Mahendra Singh
  Frontiers in Oncology 2021 DOI: 10.3389/fonc.2021.619351
  +Save
• Diverse Stakeholders of Tumor Metabolism: An Appraisal of the Emerging Approach of Multifaceted Metabolic Targeting by 3-Bromopyruvate.
  Saveg Yadav, Shrish Kumar Pandey, Yugal Goel

  +2 more

  • Mithlesh Kumar Temre
  • Sukh Mahendra Singh
  Frontiers in pharmacology 2019 DOI: 10.3389/fphar.2019.00728
  +Save
• Antimetabolic Agent 3-Bromopyruvate Exerts Myelopotentiating Action in a Murine Host Bearing a Progressively Growing Ascitic Thymoma.
  Saveg Yadav, Shrish Kumar Pandey, Yugal Goel

  +2 more

  • Mithlesh Kumar Temre
  • Sukh Mahendra Singh
  Immunological investigations 2019 DOI: 10.1080/08820139.2019.1627368
  +Save
• Molecular docking of anti-inflammatory drug diclofenac with metabolic targets: Potential applications in cancer therapeutics.
  Shrish Kumar Pandey, Saveg Yadav, Yugal Goel +3 more
  Journal of theoretical biology 2019 DOI: 10.1016/j.jtbi.2019.01.020
  +Save
• Tracking acetate through a journey of living world: Evolution as alternative cellular fuel with potential for application in cancer therapeutics.
  Shrish Kumar Pandey, Saveg Yadav, Mithlesh Kumar Temre

  +1 more

  • Sukh Mahendra Singh
  Life sciences 2018 DOI: 10.1016/j.lfs.2018.11.004
  +Save